Daily Policy Digest

Health Issues

Inventing New Drugs Is Costly, but Not Inventing Them is Costlier

The total cost to develop and gain marketing approval for a new drug is an estimated $2.6 billion...

Repealing Obamacare Will Take Some Convincing

The real obstacle to advancing an alternative to Obamacare will be interests in the health sector, which has mastered Obamacare remarkably...

Consumers on the Losing End of New Drug Plan Regulations

Blatant protectionism through restrictive drug plan regulations may be touted as consumer protections, but more often than not they benefit local pharmacy service providers at the expense of consumers...

MACRA Is Not Cutting It

Medicare Doc Fix Adds $500 Billion to National Debt...

The Senate Should Not Rush Approving MACRA

Medicare’s Physician Fee Schedule is tied to an inflation formula that is inadequate to pay physicians enough to keep seeing Medicare patients...

The Medicare Doc Fix Needs fixed

If the doc fix were similarly limited to a two-year extension, instead of perpetually locking in spending, the gross cost of the change would drop from $175 billion to about $26 billion...

Does Pharma Have a Productivity Problem?

A single drug that cured all cancers would be immensely more valuable than 100 new molecules that treated acne...

Is Obamacare Winning Over Republican Lawmakers?

Last week's overwhelming bipartisan support in the House of Representatives for a deal to lock in Obamacare's way of paying doctors sends a terrible signal...

Boehner and Pelosi's Medicare Doc Fix to Cost Billions

H.R.2 bill increases spending on the Children's Health Insurance Program (CHIP) by almost $40 billion...

The Burr-Hatch-Upton Plan v. The Affordable Care Act

If the plaintiffs succeed in overturning ACA's health insurance subsidies, it could pave the way for the Patient CARE Act to be inaugurated as a viable alternative to many ACA mandates...


2 3 4 5 6 7 8  Older »